Literature DB >> 9067920

Risk factors of end-stage renal disease and serum creatinine in a community-based mass screening.

K Iseki1, Y Ikemiya, K Fukiyama.   

Abstract

This study evaluated risk factors for end-stage renal disease (ESRD) and the prognostic significance of serum creatinine levels in a community-based mass screening. We used the registries of both community-based mass screening and chronic dialysis programs. In 1983, a total of 107,192 subjects over 18 years of age (51,122 men and 56,070 women) participated in a mass-screening program in Okinawa, Japan. Among them, serum creatinine data were available for 14,609 participants (5,613 men and 8,996 women). During 10 years of follow-up, we identified 60 dialysis patients (29 men and 31 women) among this group. Logistic regression analysis on the risk of ESRD was performed to determine the significance of serum creatinine levels in comparison with other clinical variables. The adjusted odds ratio (95% confidence interval) was 5.31 (3.39 to 8.32) in men and 3.92 (2.88 to 5.34) in women when compared to baseline serum creatinine levels of less than 1.0 mg/dl in women and 1.2 mg/dl in men. Diastolic blood pressure was not a significant predictor of ESRD. Results demonstrated the prognostic significance of serum creatinine in a community-based mass screening. Gender difference in the incidence of ESRD was explained, at least partly, by differences between clinical predictors and baseline serum creatinine levels.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9067920     DOI: 10.1038/ki.1997.119

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  19 in total

1.  Kidney cancer: treatment of clinically localized renal tumors in the elderly.

Authors:  Frederik C Roos; Joachim W Thüroff
Journal:  Nat Rev Urol       Date:  2011-10-11       Impact factor: 14.432

Review 2.  Classifying kidney problems: can we avoid framing risks as diseases?

Authors:  Catherine M Clase; Amit X Garg; Bryce A Kiberd
Journal:  BMJ       Date:  2004-10-16

3.  Risk factors for end-stage renal disease: 25-year follow-up.

Authors:  Chi-yuan Hsu; Carlos Iribarren; Charles E McCulloch; Jeanne Darbinian; Alan S Go
Journal:  Arch Intern Med       Date:  2009-02-23

4.  Serum uric acid levels are associated with polymorphisms in the SLC2A9, SF1, and GCKR genes in a Chinese population.

Authors:  Xue Sun; Feng Jiang; Rong Zhang; Shan-shan Tang; Miao Chen; Dan-feng Peng; Jing Yan; Tao Wang; Shi-yun Wang; Yu-qian Bao; Cheng Hu; Wei-ping Jia
Journal:  Acta Pharmacol Sin       Date:  2014-10-06       Impact factor: 6.150

Review 5.  Renal protection and antihypertensive drugs: current status.

Authors:  A Salvetti; P Mattei; I Sudano
Journal:  Drugs       Date:  1999-05       Impact factor: 9.546

6.  An optimal method for measuring biomarkers: colorimetric optical image processing for determination of creatinine concentration using silver nanoparticles.

Authors:  Ramin Narimani; Mehdi Azizi; Mahdad Esmaeili; Seyed Hossein Rasta; Hamid Tayebi Khosroshahi
Journal:  3 Biotech       Date:  2020-09-03       Impact factor: 2.406

Review 7.  Renal failure (chronic).

Authors:  Catherine Clase
Journal:  BMJ Clin Evid       Date:  2011-05-25

8.  Underestimation of impaired kidney function with serum creatinine.

Authors:  M Kannapiran; D Nisha; A Madhusudhana Rao
Journal:  Indian J Clin Biochem       Date:  2010-11-19

Review 9.  Early detection of CKD: the benefits, limitations and effects on prognosis.

Authors:  Adeera Levin; Paul E Stevens
Journal:  Nat Rev Nephrol       Date:  2011-06-28       Impact factor: 28.314

Review 10.  Chronic kidney disease.

Authors:  Catherine M Clase; Andrew Smyth
Journal:  BMJ Clin Evid       Date:  2015-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.